• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ATP敏感性钾通道、腺苷和一氧化氮介导的机制参与运动时的冠状动脉舒张。

ATP-sensitive K+ channels, adenosine, and nitric oxide-mediated mechanisms account for coronary vasodilation during exercise.

作者信息

Ishibashi Y, Duncker D J, Zhang J, Bache R J

机构信息

Department of Medicine, University of Minnesota Medical School, Minneapolis 55455, USA.

出版信息

Circ Res. 1998 Feb 23;82(3):346-59. doi: 10.1161/01.res.82.3.346.

DOI:10.1161/01.res.82.3.346
PMID:9486663
Abstract

We previously reported that combined blockade of adenosine receptors and ATP-sensitive K+ channels (K+(ATP) channels) blunted but did not abolish the response of coronary blood flow to exercise. This study tested the hypothesis that the residual increase in coronary flow in response to exercise after adenosine receptor and K+(ATP) channel blockade is dependent on endogenous NO. Dogs were studied at rest and during a four-stage treadmill exercise protocol under control conditions, during K+(ATP) channel blockade with glibenclamide (50 microg x kg(-1) x min(-1) i.c.) in the presence of adenosine receptor blockade with 8-phenyltheophylline (8-PT, 5 mg/kg i.v.), and after the addition of the NO synthase inhibitor N(G)-nitro-L-arginine (LNNA, 1.5 mg/kg i.c.). During control conditions, coronary blood flow was 49 +/- 3 mL/min at rest and increased to 92 +/- 8 mL/min at peak exercise. LNNA alone or in combination with 8-PT did not alter resting coronary flow and did not impair the normal increase in flow during exercise, indicating that when K+(ATP) channels are intact, neither NO nor adenosine-dependent mechanisms are obligatory for maintaining coronary blood flow. Combined K+(ATP) channel and adenosine blockade decreased resting coronary flow to 27 +/- 3 mL/min (P<.05), but exercise still increased flow to 45 +/- 5 mL/min (P<.05). The subsequent addition of LNNA further decreased resting coronary flow to 20 +/- 2 mL/min and markedly blunted exercise-induced coronary vasodilation (coronary vascular conductance, 0.20 +/- 0.03 mL x min(-1) x mm Hg(-1) at rest versus 0.24 +/- 0.04 mL x min(-1) x mm Hg(-1) during the heaviest level of exercise; P=.22), so that coronary flow both at rest and during exercise was below the control resting level. The findings suggest that K+(ATP) channels are critical for maintaining coronary vasodilation at rest and during exercise but that when K+(ATP) channels are blocked, both adenosine and NO act to increase coronary blood flow during exercise. In the presence of combined K+(ATP) channel blockade and adenosine receptor blockade, NO was able to produce approximately one quarter of the coronary vasodilation that occurred in response to exercise when all vasodilator systems were intact.

摘要

我们之前报道过,联合阻断腺苷受体和ATP敏感性钾通道(K⁺(ATP)通道)可减弱但并未消除冠状动脉血流对运动的反应。本研究检验了以下假设:在腺苷受体和K⁺(ATP)通道被阻断后,运动引起的冠状动脉血流残余增加依赖于内源性一氧化氮(NO)。研究了犬在静息状态下以及在四个阶段的跑步机运动方案过程中的情况,分别处于对照条件下、在用格列本脲(50μg·kg⁻¹·min⁻¹,腹腔注射)阻断K⁺(ATP)通道且同时用8-苯基茶碱(8-PT,5mg/kg,静脉注射)阻断腺苷受体的情况下,以及在添加一氧化氮合酶抑制剂N(G)-硝基-L-精氨酸(LNNA,1.5mg/kg,腹腔注射)之后。在对照条件下,静息时冠状动脉血流为49±3mL/min,运动峰值时增加至92±8mL/min。单独使用LNNA或与8-PT联合使用均未改变静息冠状动脉血流,也未损害运动期间血流的正常增加,这表明当K⁺(ATP)通道完整时,NO和腺苷依赖性机制对于维持冠状动脉血流并非必需。联合阻断K⁺(ATP)通道和腺苷可使静息冠状动脉血流降至27±3mL/min(P<0.05),但运动仍使血流增加至45±5mL/min(P<0.05)。随后添加LNNA进一步使静息冠状动脉血流降至20±2mL/min,并显著减弱运动诱导的冠状动脉血管舒张(冠状动脉血管传导性,静息时为0.20±0.03mL·min⁻¹·mmHg⁻¹,运动最剧烈时为0.24±0.04mL·min⁻¹·mmHg⁻¹;P = 0.22),以至于静息和运动时的冠状动脉血流均低于对照静息水平。这些发现表明,K⁺(ATP)通道对于在静息和运动时维持冠状动脉血管舒张至关重要,但当K⁺(ATP)通道被阻断时,腺苷和NO在运动期间均发挥作用以增加冠状动脉血流。在联合阻断K⁺(ATP)通道和腺苷受体的情况下,NO能够产生在所有血管舒张系统完整时运动引起的冠状动脉血管舒张的约四分之一。

相似文献

1
ATP-sensitive K+ channels, adenosine, and nitric oxide-mediated mechanisms account for coronary vasodilation during exercise.ATP敏感性钾通道、腺苷和一氧化氮介导的机制参与运动时的冠状动脉舒张。
Circ Res. 1998 Feb 23;82(3):346-59. doi: 10.1161/01.res.82.3.346.
2
K(ATP)(+) channels, nitric oxide, and adenosine are not required for local metabolic coronary vasodilation.局部代谢性冠状动脉血管舒张不需要ATP敏感性钾通道、一氧化氮和腺苷。
Am J Physiol Heart Circ Physiol. 2001 Feb;280(2):H868-75. doi: 10.1152/ajpheart.2001.280.2.H868.
3
Role of K(+)(ATP) channels and adenosine in regulation of coronary blood flow in the hypertrophied left ventricle.K(+)(ATP)通道和腺苷在肥厚左心室冠状动脉血流调节中的作用。
Am J Physiol. 1999 Aug;277(2 Pt 2):H617-25. doi: 10.1152/ajpheart.1999.277.2.H617.
4
Endogenous adenosine mediates coronary vasodilation during exercise after K(ATP)+ channel blockade.在钾离子通道(K(ATP))阻断后运动期间,内源性腺苷介导冠状动脉舒张。
J Clin Invest. 1995 Jan;95(1):285-95. doi: 10.1172/JCI117653.
5
Role of K+ ATP channels and adenosine in the regulation of coronary blood flow during exercise with normal and restricted coronary blood flow.钾离子ATP通道和腺苷在正常及受限冠状动脉血流运动过程中对冠状动脉血流调节的作用。
J Clin Invest. 1996 Feb 15;97(4):996-1009. doi: 10.1172/JCI118524.
6
Role of K+ATP channels in coronary vasodilation during exercise.钾离子ATP通道在运动时冠状动脉舒张中的作用。
Circulation. 1993 Sep;88(3):1245-53. doi: 10.1161/01.cir.88.3.1245.
7
Coronary blood flow regulation in exercising swine involves parallel rather than redundant vasodilator pathways.运动猪的冠状动脉血流调节涉及并行而非冗余的血管舒张途径。
Am J Physiol Heart Circ Physiol. 2003 Jul;285(1):H424-33. doi: 10.1152/ajpheart.00916.2002. Epub 2003 Mar 13.
8
Effect of K+ATP channel and adenosine receptor blockade during rest and exercise in congestive heart failure.充血性心力衰竭患者静息和运动时钾离子ATP通道及腺苷受体阻断的作用
Circ Res. 2007 Jun 8;100(11):1643-9. doi: 10.1161/CIRCRESAHA.107.150219. Epub 2007 May 3.
9
Effects of combined inhibition of ATP-sensitive potassium channels, nitric oxide, and prostaglandins on hyperemia during moderate exercise.三磷酸腺苷敏感性钾通道、一氧化氮和前列腺素联合抑制对中等强度运动期间充血的影响。
J Appl Physiol (1985). 2006 May;100(5):1506-12. doi: 10.1152/japplphysiol.01639.2005. Epub 2006 Feb 9.
10
Role of NO and K(+)(ATP) channels in adenosine-induced vasodilation on in vivo canine subendocardial arterioles.一氧化氮和钾离子ATP通道在腺苷诱导的犬体内心内膜下小动脉血管舒张中的作用。
Am J Physiol. 1999 Nov;277(5):H1931-9. doi: 10.1152/ajpheart.1999.277.5.H1931.

引用本文的文献

1
Synthetic Small-Molecule Ligands Targeted to Adenosine Receptors: Is There Potential Towards Ischemic Heart Disease?靶向腺苷受体的合成小分子配体:对缺血性心脏病有潜在作用吗?
Cells. 2025 Aug 7;14(15):1219. doi: 10.3390/cells14151219.
2
Ketone Bodies in the Regulation of Myocardial Perfusion in Cardiovascular Disease: Metabolic and Vasodilatory Effects.酮体在心血管疾病中对心肌灌注的调节作用:代谢和血管舒张效应
Int J Mol Sci. 2025 May 19;26(10):4856. doi: 10.3390/ijms26104856.
3
Unraveling the Gordian knot of coronary pressure-flow autoregulation.
解开冠状动脉压力-血流自动调节的戈尔迪之结。
J Mol Cell Cardiol. 2024 May;190:82-91. doi: 10.1016/j.yjmcc.2024.04.008. Epub 2024 Apr 11.
4
Review of cardiac-coronary interaction and insights from mathematical modeling.心脏-冠状动脉相互作用的研究进展及数学建模的启示
WIREs Mech Dis. 2024 May-Jun;16(3):e1642. doi: 10.1002/wsbm.1642. Epub 2024 Feb 5.
5
Thin, soft, wearable system for continuous wireless monitoring of artery blood pressure.薄型、柔软、可穿戴的系统,用于连续无线监测动脉血压。
Nat Commun. 2023 Aug 17;14(1):5009. doi: 10.1038/s41467-023-40763-3.
6
Protection against Ischemic Heart Disease: A Joint Role for eNOS and the K Channel.预防缺血性心脏病:eNOS 和 K 通道的共同作用。
Int J Mol Sci. 2023 Apr 27;24(9):7927. doi: 10.3390/ijms24097927.
7
Pericytes and the Control of Blood Flow in Brain and Heart.周细胞与脑、心血流的调控
Annu Rev Physiol. 2023 Feb 10;85:137-164. doi: 10.1146/annurev-physiol-031522-034807.
8
Purinergic signaling in myocardial ischemia-reperfusion injury.嘌呤能信号在心肌缺血再灌注损伤中的作用。
Purinergic Signal. 2023 Mar;19(1):229-243. doi: 10.1007/s11302-022-09856-4. Epub 2022 Mar 7.
9
Mechanobiology of Microvascular Function and Structure in Health and Disease: Focus on the Coronary Circulation.健康与疾病状态下微血管功能和结构的力学生物学:聚焦于冠状动脉循环
Front Physiol. 2021 Dec 23;12:771960. doi: 10.3389/fphys.2021.771960. eCollection 2021.
10
Disentangling the Gordian knot of local metabolic control of coronary blood flow.解析冠状动脉血流局部代谢控制的戈尔迪乌姆之结。
Am J Physiol Heart Circ Physiol. 2020 Jan 1;318(1):H11-H24. doi: 10.1152/ajpheart.00325.2019. Epub 2019 Nov 8.